Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 166; no. 3; pp. 675 - 678
Main Authors Imafuku, S., Ito, K., Nakayama, J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.03.2012
Wiley-Blackwell
Subjects
Adalimumab
Adult
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized - adverse effects
Arthritis, Psoriatic - drug therapy
Biological and medical sciences
Dermatologic Agents - adverse effects
Dermatology
Female
Humans
Infliximab
Medical sciences
Pseudolymphoma - chemically induced
Psoriasis. Parapsoriasis. Lichen
Human
Immunomodulator
Skin disease
Infliximab
Psoriasis
Dermatology
Pseudolymphoma
Antipsoriatic agent
Lymphoid hyperplasia
Skin
Immunosuppressive agent
Adalimumab
Online AccessGet full text

Cover

More Information
Bibliography:ArticleID:BJD10607
istex:48C15A8C942E232CBF5B7F4953421B67E0926CD3
ark:/67375/WNG-2GL3N6S2-4
Conflicts of interest: none declared.
Funding sources: none.
ISSN:0007-0963
1365-2133
DOI:10.1111/j.1365-2133.2011.10607.x